Tea

Tea (Camellia sinensis): A Comprehensive Reference

1. Identity and Botanical Description

Tea, Camellia sinensis, belongs to the family Theaceae and is a shrub or evergreen tree that can grow up to 16 m in height. Tea is commonly produced from the fresh leaves of two widely cultivated varieties: Camellia sinensis var. sinensis and C. sinensis var. assamica. The two principal varietal forms are C. sinensis var. sinensis, better known as China bush, and C. sinensis var. assamica, also known as Assam bush, although altogether there are more than a thousand sub-varieties of C. sinensis.

The leaves may vary from exstipulate, lanceolate to obovate up to 30 cm long and 2–5 cm broad, pubescent, sometimes becoming glabrous, serrate, and acute or acuminate. The plant is found mainly in the tropical and temperate regions of Asia, especially in China, Sri Lanka, Japan, and India.

Types of Tea and Processing

The plant Camellia sinensis is the source of different teas — white, green, yellow, oolong, black, and pu-erh — consumed worldwide, which are classified by the oxidation degree of their bioactive compounds. The degree of processing fundamentally determines the chemical profile of each type:

• Green tea is produced through a non-fermented process in which fresh leaves are rapidly heated (by steaming or pan-firing) to deactivate oxidative enzymes, thereby preserving a high catechin content.
• Black tea is fully oxidized. The dissimilarity between green tea and black tea is due to the processing methods adopted during manufacturing.
• Oolong tea is partially oxidized. It is a traditional semi-oxidized Chinese tea produced through a process that includes withering the leaves under strong sun and allowing some oxidation to occur before curling and twisting. Most oolong teas, especially those of fine quality, involve unique tea plant cultivars. The degree of oxidation can range from 8% to 85% depending on the variety and production style.
• White tea originates primarily from the flower buds and young leaves of the plant and undergoes minimal processing.
• Pu-erh tea undergoes a prolonged microbial fermentation process, producing a chemically distinct profile.

Common Forms and Preparations

All types of tea — green, black, oolong, and white — are produced from the Camellia sinensis plant using different methods. Tea is usually brewed and drunk as a beverage, but green tea extracts are also sold in capsules and sometimes used in skin products. Teas are commonly prepared as an infusion by adding the plant matrix to a container with boiling water (up to 100 °C), capping, and letting it rest for 5 to 10 minutes, after which the liquid is used for consumption or scientific research. Other forms include powdered preparations (matcha), compressed tea bricks (pu-erh), and standardized dry extracts standardized to a specified EGCG percentage.

2. Traditional and Historical Use

China: Origins and Early Medical Use

Tea, a culturally significant beverage, originated around 2700 B.C. in ancient Chinese civilization, with a profound understanding of its therapeutic properties. The earliest credible evidence of tea consumption dates to the Shang Dynasty (1500–1046 BCE) in China's Yunnan province, where wild tea trees still grow today. Archaeological evidence from the Han Dynasty (206 BCE–220 CE) confirms that tea was already being processed and traded in China by that period.

Green tea was first documented as a therapeutic substance in the Shennong Ben Cao Jing, a foundational traditional Chinese medicine (TCM) text attributed to the legendary emperor Shennong around 2737 BCE. The earliest recorded medicinal use of tea in China describes tea as a substance that "makes one think better, sleep less, become lighter, and see more clearly." For much of its early history in China, tea was consumed primarily as medicine rather than as a social beverage.

In TCM pharmacology, green tea is classified as a "bitter and sweet, cool" herb, believed to clear heat, resolve dampness, promote alertness, and support digestion. In its early days, tea was consumed more as a medicinal elixir than a beverage for leisure; Chinese medicine recognized its potential benefits, attributing properties like improved digestion and mental alertness to its consumption.

The Tang and Song Dynasties: Codification of Tea Culture

During the Tang Dynasty (618–907 CE), Lu Yu wrote the Cha Jing (Classic of Tea) — the world's first comprehensive treatise on tea cultivation, preparation, and philosophy — which elevated tea from a medicinal herb to a cultural practice. By the time of the Tang Dynasty, tea was the national drink of China, spreading from court circles to be popular throughout Chinese society. At this time, it was manufactured in brick form: the tea leaves were pounded and pressed into a brick-shaped mold, then dried.

By the Song Dynasty (960–1279), powdered tea whisked in bowls had become the standard preparation — a method that would later evolve into Japanese matcha. The Ming Dynasty (1368–1644) marked a revolution with the abandonment of compressed bricks in favor of infused leaves, a practice that had lasting influence on the accessories linked to preparation, such as porcelain teapots.

Japan: The Tea Ceremony

Tea arrived in Japan in the 7th century, introduced by Buddhist monks returning from China. The Japanese tea ceremony (chanoyu) evolved gradually from a variety of tea drinking practices that became formalized through the influence of Buddhist thought. During the 16th century, tea masters perfected the meticulous orchestration of preparing and serving tea as a means to mindfulness and enlightenment. In the Japanese tea ceremony (chanoyu), tea is not only a hydrating and stimulating beverage but also takes on a symbolic dimension, the aim of which is to return to oneself and become aware of the beauty and simplicity of the present moment.

Spread to the West

Tea eventually found its way to Europe through trade routes established by Portuguese and Dutch explorers. It was Catherine of Braganza, a Portuguese princess who married King Charles II of England in the mid-17th century, who popularized tea in England. Her introduction of the tea-drinking custom transformed tea into an integral part of English culture. Tea consumption is considered second only to water globally. Black tea is consumed predominantly in Western and some Asian countries, and green tea is consumed predominantly in China, Japan, India, and a few countries in North Africa and the Middle East.

3. Key Constituents and Active Compounds

The complex chemical composition of green tea comprises different classes of chemical compounds, such as polyphenols, alkaloids, proteins, minerals, vitamins, amino acids, and others. Tea is reported to contain nearly 4,000 bioactive compounds, of which one-third is contributed by polyphenols.

Polyphenols / Catechins (Flavan-3-ols)

Flavan-3-ols, mainly characterized by epicatechins, catechins, and their derivatives, represent on average 60% of the bioactive compounds in teas. As predominant polyphenols in tea, catechins constitute approximately 30% of the dry mass of tea leaves. Major green tea polyphenols encompass (−)-epicatechin (EC), (−)-epicatechin gallate (ECG), (−)-epigallocatechin (EGC), and (−)-epigallocatechin gallate (EGCG). EGCG is the most abundant among green tea catechins at approximately 60% of total catechin content.

Measured catechin levels in brewed green tea infusions show considerable variation. Levels of EGCG range from 117 to 442 mg/L, EGC from 203 to 471 mg/L, ECG from 16.9 to 150 mg/L, epicatechin (EC) from 25 to 81 mg/L, and catechin (C) from 9.03 to 115 mg/L.

Black tea contains substantially fewer catechins than green tea due to oxidation, which converts catechins into theaflavins and thearubigins — larger, complex polyphenols unique to black and oolong teas.

Methylxanthines

Among other components, methylxanthine derivatives (caffeine, theobromine, theophylline) are present in fresh leaves. Caffeine contents in green tea infusions typically range between 141–338 mg/L. Caffeine is a well-characterized adenosine receptor antagonist that mediates many of tea's stimulatory and cognitive effects. Theophylline, present in smaller amounts, has established bronchodilatory properties. Theobromine is a mild stimulant and vasodilator.

Amino Acids: L-Theanine

The sensory and functional properties of teas are affected by the amount of methylxanthines (caffeine and theobromine), amino acids (L-theanine), and reducing sugars in their composition. L-theanine is an amino acid found notably in green tea, black tea, and some mushrooms. It is known for enhancing cognitive function, particularly attention. L-theanine is structurally similar to glutamate and has been identified as a partial modulator of glutamate neurotransmission and GABA-A receptors. Its concentration is particularly high in the shade-grown tea used for matcha.

Other Constituents

The flowers and leaves of Camellia sinensis have a rich composition of bioactive compounds including phenolic acids, flavonoids, tannins, alkaloids (methylxanthines), and nutrients (carbohydrates, proteins, and minerals). Phytochemical study has led to the identification of 398 compounds across the tea plant genus, including hydrolyzable tannins, flavan-3-ols, flavonoids, terpenoids, alkaloids, and other phenolic compounds. Mineral constituents include potassium, manganese, fluoride, calcium, and trace quantities of aluminium and iron.

4. Mechanisms of Action

Antioxidant Activity

Catechins are dietary polyphenolic compounds associated with a wide variety of beneficial health effects in vitro, in vivo, and clinically. These therapeutic properties have long been attributed to the catechins' antioxidant and free radical scavenging effects. Emerging evidence has shown that catechins and their metabolites have many additional mechanisms of action by affecting numerous sites, potentiating endogenous antioxidants, and eliciting dual actions during oxidative stress, ischemia, and inflammation.

The most widely recognized properties of tea polyphenols are their antioxidant activities, arising from their ability to scavenge reactive oxygen species. Tea polyphenols also bind to metal ions, preventing these ions from participating in peroxidative reactions. Green and black tea and isolated tea polyphenols have been shown to scavenge reactive oxygen and nitrogen species, and to reduce their damage to lipid membranes, proteins, and nucleic acids in cell-free systems.

Anti-Inflammatory Mechanisms

EGCG acts as an antioxidant to scavenge reactive oxygen species, leading to attenuation of nuclear factor-κB (NF-κB) activity. One key mechanism is the inhibition of NF-κB, a key oxidative stress-sensitive transcription factor. Anti-inflammatory effects are activated through a variety of mechanisms, including modulation of nitric oxide synthase isoforms.

Signal Transduction and Transcriptional Regulation

EGCG directly interacts with proteins and phospholipids in the plasma membrane and regulates signal transduction pathways, transcription factors, DNA methylation, mitochondrial function, and autophagy to exert many of its biological actions. Catechins have proven to modulate apoptosis at various points in the sequence, including altering expression of anti- and pro-apoptotic genes.

EGCG Receptor Interactions

Treatment with EGCG reduces expression of toll-like receptor 4 (TLR4) and increases expression of tollip, a negative regulator of TLRs, through a 67LR-dependent mechanism. Notably, based on its chemical structure, EGCG is often classified as an antioxidant; however, treatment of cells with EGCG can result in production of hydrogen peroxide and hydroxyl radicals in the presence of Fe(III), meaning EGCG functions as a pro-oxidant in some cellular contexts.

L-Theanine Mechanisms

L-theanine has multiple mechanisms of action: it is a glutamate reuptake inhibitor; in the hippocampus, it is a competitive low-affinity glutamate receptor antagonist; and it acts on GABA-A receptors, conferring a neuroprotective effect for neurons. Whether directly or indirectly, caffeine and L-theanine have been shown to affect several neurotransmitter systems including dopamine, serotonin, glutamate, and GABA.

5. Scientific Evidence by Area of Use

5.1 Cardiovascular Health

The limited evidence currently available suggests that both green and black tea might have beneficial effects on some heart disease risk factors, including blood pressure and cholesterol. Very few long-term studies have looked at the effects of tea on heart disease risk.

A large meta-analysis and systematic review examined the effects of green tea supplementation on cardiovascular risk factors across multiple RCTs. This meta-analysis summarized the effects of green tea supplementation on cardiovascular risk factors including glycemic control markers (FBS, HbA1c, HOMA-IR, fasting insulin), blood pressure (SBP and DBP), lipid profile (TG, TC, LDL, HDL), and C-reactive protein (CRP). Overall, clinical trials with a total of 4,874 participants were included, with participants' mean age ranging between 18 and 68.7 years, and the period of intervention ranging between two to 48 weeks.

With respect to coronary artery disease (CAD), a systematic review and dose-response meta-analysis found that while black tea drinking was not associated with a lower risk of CAD, green tea consumption was associated with a reduced risk of CAD. Evidence in this area is considered preliminary and observational in large part, with confounding factors such as diet, lifestyle, and population differences complicating interpretation.

A meta-analysis of RCTs found that green tea catechin supplementation was associated with improved lipid profiles. One clinical RCT showed that EGCG supplementation significantly reduced fasting plasma triglyceride (TG) levels after 8 weeks of green tea catechin supplementation in obese individuals. Results indicated that EGCG significantly reduced TG levels in overweight and obese people. An umbrella review noted that green tea and its bioactive constituents have beneficial effects on body weight, blood pressure, blood glucose, and lipids.

Strength of evidence (cardiovascular): Moderate, but largely from short-term RCTs and observational studies. Long-term interventional evidence is lacking, and the clinical magnitude of effects is modest.

5.2 Body Weight and Metabolic Syndrome

Green tea catechin has been reported to effectively help control body weight in overweight and obese populations and is protective against blood pressure and lipids in people with type 2 diabetes and metabolic syndrome.

A grade-assessed systematic review and dose–response meta-analysis of RCTs evaluated the effects of green tea extract supplementation on body composition. Results indicated improvements across measures, with a statistically significant reduction in BMI (MD: −0.69; 95% CI: −0.95 to −0.42; p < 0.001) compared to those who did not consume green tea.

Strength of evidence (weight management): Modest. While some RCTs show statistically significant reductions in body weight and BMI, the absolute effect sizes are small, and results across studies are heterogeneous. Green tea catechins alone are unlikely to produce clinically meaningful weight loss without dietary and behavioral changes.

5.3 Blood Glucose and Type 2 Diabetes

Multiple RCTs have examined green tea or GTE supplementation on glycemic markers. Some individual trials did not report a significant reduction in TC, triglyceride, LDL, or glycemic control markers in diabetic patients following 8-week consumption of four cups of green tea compared to control. However, meta-analytic data across larger trial compilations suggest modest improvements in fasting blood glucose and insulin sensitivity.

Strength of evidence (glycemic control): Preliminary to moderate. Results across RCTs are inconsistent and effect sizes are small. More robust, longer-term trials in well-characterized diabetic populations are needed.

5.4 Cognition, Mood, and Neurological Function

A systematic review and meta-analysis of RCTs assessed the effects of tea, L-theanine alone, or L-theanine plus caffeine on cognition and mood. The main findings were that theanine plus caffeine likely confers small-to-moderate improvements, compared to placebo, in attentional task performance and may benefit certain mood outcomes, primarily in the second hour after intake, and that theanine alone may confer small-to-moderate improvements on cognitive performance measures during the first and second hours after intake, in healthy adults. Current evidence points toward beneficial effects of tea, or theanine plus caffeine, on cognition and mood, mostly being driven by caffeine, but the presence and magnitude of positive effects appears to be inconsistent, possibly due to variations in assessment methods and doses of caffeine and theanine.

A separate meta-analysis of 11 RCTs of tea constituents found evidence of moderate effect sizes in favor of combined caffeine and L-theanine in the first 2 hours post-dose for outcome measures including Bond-Lader alertness and attentional switching accuracy.

Regarding neuroprotection, EGCG, the most abundant polyphenol in green tea, has emerged as a promising therapeutic agent due to its potent antioxidant and anti-inflammatory effects. Chronic neuroinflammation and oxidative stress are key pathological mechanisms in neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD). EGCG has neuroprotective efficacy due to scavenging free radicals, reducing oxidative stress, and attenuating neuroinflammatory processes. However, evidence in humans for clinically meaningful neuroprotection from tea consumption remains preliminary, and most mechanistic data derive from preclinical studies.

Strength of evidence (cognition/mood): Moderate for acute effects of combined caffeine and L-theanine on attentional performance. Preliminary for long-term neuroprotection, with most data from in vitro and animal studies.

5.5 Cancer Prevention

A systematic review of 43 epidemiological studies, four randomized trials, and one meta-analysis examined the relationship between green tea and cancer. While some evidence suggests that green tea has beneficial effects on gastrointestinal cancers, the findings are not consistent. Green tea may have beneficial effects on cancer prevention, but further large and long-term cohort studies and clinical trials are warranted.

The anti-cancer role of EGCG has been investigated in various types of cancer. EGCG has been shown to possess a chemopreventive effect through inhibition of carcinogenesis processes such as initiation, promotion, and progression. This catechin has also demonstrated a role in cancer management through modulating various cell signaling pathways such as regulating proliferation, apoptosis, angiogenesis, and killing of various types of cancer cells. These findings are largely from preclinical (in vitro and animal) studies.

Regarding female hormone-dependent cancers, a meta-analysis found that although preclinical studies indicate that green tea extracts and polyphenols exhibit anti-tumor effects without mimicking estrogen like phytoestrogens, clinical evidence remains scarce.

Strength of evidence (cancer): Weak to preliminary in humans. Substantial preclinical mechanistic data exist, but clinical RCT evidence is largely absent. Epidemiological studies are inconsistent and subject to significant confounding. No regulatory body has approved a cancer prevention claim for tea or tea extracts.

5.6 All-Cause and CVD Mortality

A large prospective cohort study using data from the Shanghai Men's Health Study and Shanghai Women's Health Study found that during a median follow-up of 8.3 and 14.2 years for men and women respectively, green tea consumption was inversely associated with risk of all-cause mortality (HR 0.95; 95% CI, 0.90–1.01), particularly among never-smokers (HR 0.89; 95% CI, 0.82–0.96). While some meta-analyses have indicated an association of green tea consumption with lower risk of total and CVD mortality, the evidence was mainly based on Japanese populations.

5.7 Bone Health

The health benefits of tea consumption in preventing cancers and cardiovascular diseases have been intensively investigated, but limited information is available about the protective effect of tea or its bioactive components on bone health. Published results on bone mineral density (BMD) and tea consumption are all based on cross-sectional or retrospective studies, and are therefore inconsistent, which may compromise the quality of evidence. Some studies have suggested no significant link between coffee or tea consumption and BMD, and evidence of a causal role of tea in osteoporosis is lacking.

Strength of evidence (bone health): Insufficient. Available data are epidemiological and cross-sectional; no high-quality interventional evidence currently supports a bone health benefit from tea consumption.

5.8 Oral Health

Green tea has been explored in recent years for its beneficial effects on oral health. Laboratory studies have demonstrated antimicrobial activity of tea catechins against cariogenic bacteria and periodontal pathogens. However, robust clinical trial evidence in humans remains limited, and the evidence base for specific oral health endpoints is predominantly preclinical.

6. Body Systems and Health Areas of Association

• Cardiovascular system: Lipid-lowering, antihypertensive, antiatherosclerotic effects (RCT and meta-analytic evidence of modest benefit).
• Metabolic system: Body weight, BMI, fasting blood glucose, insulin sensitivity (modest benefit in meta-analyses).
• Central nervous system: Acute cognitive effects via caffeine and L-theanine; preliminary neuroprotective interest in Alzheimer's and Parkinson's disease.
• Gastrointestinal system: Historical and emerging evidence for anti-inflammatory and prebiotic effects; limited clinical data.
• Oncology: Extensive preclinical interest; inconsistent and insufficient human clinical evidence.
• Hepatic system: Antioxidant protection of hepatocytes in animal models; paradoxically, high-dose GTE is associated with hepatotoxic risk.
• Musculoskeletal system: Epidemiological associations with BMD; insufficient interventional evidence.
• Oral/dental health: Antimicrobial properties documented in vitro; limited clinical evidence.
• Immune system: Anti-inflammatory and immunomodulatory activity demonstrated predominantly in preclinical models.

7. Dosage Forms and Reported Dosages

Green tea may be consumed in the form of a brewed beverage or capsular extract. In some countries, tea is used as a dietary supplement. There is currently no established recommended dose for green tea extract.

The following dosages appear in clinical research literature:

• A five-way crossover trial used 200 mg of L-theanine and 160 mg of caffeine, the combination of both, a single cup of black tea, and distilled water as comparators in 20 healthy adult males.
• In one systematic review, applied products for cognition studies contained caffeine (40–250 mg), EGCG (135–300 mg), and L-theanine (12–250 mg).
• In a clinical RCT examining lipid effects, EGCG supplementation was administered over 8 weeks in obese individuals.
• Across cardiovascular risk RCTs, the period of intervention ranged between two to 48 weeks.
• In a large prospective study of GTE in postmenopausal women at risk for breast cancer, GTE was associated with ALT elevations in 6.7% of patients compared to 0.7% of controls.

Brewed green tea typically delivers 100–300 mg of total catechins per cup, depending on the tea variety, water temperature, and infusion time. Standardized GTE supplements used in research are often specified at 50–90% polyphenols or a defined EGCG content, with single doses of EGCG in clinical trials ranging from approximately 135 mg to 800 mg per day.

8. Safety Considerations and Drug Interactions

Hepatotoxicity — Green Tea Extract (GTE)

Drinking green tea has not been associated with liver injury or serum aminotransferase elevations; indeed, cross-sectional studies suggest that regular use of green tea is associated with lower serum ALT and AST values. Nevertheless, case series and a systematic review by the United States Pharmacopeia have raised the issue of the potential for GTE to cause hepatotoxicity.

Preclinical and human data implicate the catechin component of green tea as the culprit of hepatotoxicity. Approximately 10% of green tea extract is composed of catechins, of which EGCG is present in the highest concentration. There is great variability in the concentration of green tea extract, EGCG, and other components among marketed products, which may explain why some products have been implicated in hepatotoxicity. Exposure of rat hepatocytes to EGCG has been shown to induce mitochondrial toxicity and generation of reactive oxygen species.

The polyphenolic catechins comprise the chemically active component of GTE. The polyphenolic backbone of the catechins is exploited for its antioxidant potential but is likely also responsible for liver injury.

A Green Tea Extract Hepatotoxicity Expert Panel was established by the USP, which conducted a comprehensive analysis of the existing literature. It was suggested that repeated oral administration of GTE, particularly during periods of fasting, increased the bioavailability but also the toxicity of catechins. One study suggests that people should not simultaneously diet and consume EGCG for weight loss, as the risk of liver injury will be significantly increased under dietary restriction.

Iron Absorption Interaction

Tea polyphenols, particularly in black and green tea, are known to form complexes with non-heme iron and reduce its intestinal absorption. This has been documented in human studies: the effect of green tea on iron status may be relevant in some populations. Evidence suggests that the reduction of iron absorption, especially in patients with low iron requirements, may protect tissue against damage caused by oxygen free radicals and iron-dependent metal lipid peroxidation. Conversely, for individuals with iron deficiency or increased iron needs, consuming tea close to iron-containing meals or supplements may impair iron status.

Drug Interactions

Some published reviews conclude that there is generally no clinically significant risk of pharmacokinetic drug interactions with tea, but nevertheless recommend caution, especially for drugs with a small therapeutic index. The focus is primarily on interactions at the pharmacokinetic level, as these are more challenging to understand and predict, and the precise mechanisms have not been adequately explored or confirmed. The best-studied interactions relate to absorption, decreased bioavailability, and modification of biotransformation of coadministered drugs. Due to the low bioavailability of green tea catechins, it is assumed that the involved interactions are primarily in the gastrointestinal tract, particularly in enterocytes, in a manner similar to how grapefruit juice interacts.

Caffeine-Related Effects

Tea contributes a meaningful dietary dose of caffeine. Caffeine can interact with stimulant medications, MAO inhibitors, anticoagulants such as warfarin (through additive stimulatory effects), and medications for sleep disorders. High caffeine intake may exacerbate insomnia, anxiety disorders, hypertension, and cardiac arrhythmias. Excessive consumption has been linked to adverse health outcomes including high blood pressure, seizures, and sleep disturbances.

Pregnancy

Tea's caffeine content is a recognized concern in pregnancy; relevant medical bodies have issued guidance on limiting caffeine intake during gestation. The American College of Obstetricians and Gynecologists has published guidance on moderate caffeine consumption during pregnancy, recommending caffeine intake be limited to less than 200 mg per day.

General Tolerability

Studies demonstrate that green tea shows versatile pharmacological activities. However, studies on the toxic effects of green tea extract and its main ingredients have also raised concerns including hepatotoxicity and DNA damage. At the level of customarily consumed brewed tea beverages, adverse effects are uncommon in healthy adults. The hepatotoxicity signal is associated specifically with concentrated GTE supplements, particularly when taken in high doses or in a fasted state, rather than with regular beverage consumption.

References

• Hernández-Hernández C, et al. "Processing, chemical signature and food industry applications of Camellia sinensis teas: An overview." PMC, 2021.
• Aboulwafa MM, et al. "A Comprehensive Insight on the Health Benefits and Phytoconstituents of Camellia sinensis and Recent Approaches for Its Quality Control." PMC, 2019.
• Fernandez PL, et al. "Chemical composition of green tea (Camellia sinensis) infusions commercialized in Portugal." PubMed, 2007.
• Chandra Mohan et al. "Green Tea (Camellia Sinensis): Chemistry and Oral Health." PMC, 2016.
• Yang Z, et al. "Plant Resources, Chemical Constituents, and Bioactivities of Tea Plants from the Genus Camellia Section Thea." J Agric Food Chem, 2019.
• Anand J, et al. "Biochemical characterization and pharmacognostic evaluation of purified catechins in green tea (Camellia sinensis) cultivars of India." PMC, 2015.
• Exploring the ancient roots and modern global brews of tea and herbal beverages: A comprehensive review. PMC, 2024.
• National Center for Complementary and Integrative Health (NCCIH). "Tea." NIH NCCIH.
• National Center for Complementary and Integrative Health (NCCIH). "Green Tea: Usefulness and Safety." NIH NCCIH.
• Chen Z, et al. "Green tea consumption and cause-specific mortality." PMC / NIH, 2017.
• Xu R, et al. "Green Tea (Camellia sinensis): A Review of Its Phytochemistry, Pharmacology, and Toxicology." PMC, 2022.
• Boehm K, et al. "Green tea (Camellia sinensis) and cancer prevention: a systematic review of randomized trials and epidemiological studies." PMC, 2009.
• Ohishi T, et al. "Anti-inflammatory Action of Green Tea." PubMed, 2016.
• Mandel SA, et al. "Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration." PubMed, 2006.
• Bao G, et al. "Neurodegenerative diseases and catechins: EGCG is a modulator of chronic neuroinflammation and oxidative stress." PMC, 2024.
• Kim HS, et al. "New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, EGCG." ScienceDirect, 2014.
• Shafique S, et al. "Potential Therapeutic Targets of EGCG, the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer." PMC, 2020.
• Zamani M, et al. "The effects of green tea supplementation on cardiovascular risk factors: A systematic review and meta-analysis." PMC, 2023.
• Effects of green tea catechin on blood pressure and lipids in overweight and obese population — a meta-analysis. PMC, 2023.
• Effects of Tea or its Bioactive Compounds L-Theanine or L-Theanine plus Caffeine on Cognition, Sleep, and Mood: A Systematic Review and Meta-Analysis of RCTs. PMC, 2025.
• Dietz C, et al. "The Cognitive-Enhancing Outcomes of Caffeine and L-theanine: A Systematic Review." PMC, 2022.
• Camfield DA, et al. "Acute effects of tea constituents L-theanine, caffeine, and EGCG on cognitive function and mood: a systematic review and meta-analysis." PubMed, 2014.
• LiverTox®: Green Tea. NCBI Bookshelf / NIH. National Library of Medicine.
• Eckert GP, et al. "Green tea extract–associated acute liver injury: Case report and review." PMC, 2022.
• Epigallocatechin Gallate During Dietary Restriction — Potential Mechanisms of Enhanced Liver Injury. PMC, 2021.
• AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury. PMC, 2023.
• Shen CL, et al. "Green Tea and Bone Metabolism." PMC, 2009.
• Coffee and tea consumption on the risk of osteoporosis: a meta-analysis. PMC, 2025.
• Green Tea: Current Knowledge and Issues. PMC, 2025.
• Yang X, et al. "Association between tea consumption and prevention of coronary artery disease: A systematic review and dose-response meta-analysis." PMC, 2022.
• Shen CL, et al. "Green tea polyphenols and Tai Chi for bone health: Designing a placebo-controlled randomized trial." PMC, 2009.
• Senbird Tea. "The History of Tea: Origins and Traditions."